User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

2594

Interactions with Platform & by Email *

INTERACTIONS

467

Unique # Participated *

PARTICIPANTS

78

Responses Validated *

VALIDATIONS

22

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Introduction.....II-1
Current and Future Analysis.....II-1
1$100
   A Glance at the Nucleic Acid Testing Market.....II-2
Point of Care (POC) Nucleic Acid Tests.....II-2
Lateral Flow Platform-An Alternative to POC Nucleic Acid Testing.....II-2
1$100
   Veterinary Industry Eyes on Nucleic Acid Testing Kits and Immunodiagnostics.....II-3
Home-Brewing Methods Continue to Dominate the NAPI Markets.....II-3
Molecular Diagnostics – A Largely Untapped Market.....II-3
1$100
   Low-Priced Commercial Products to Mar the Popularity of Conventional Nucleic Acid
  Isolation Methods.....II-4
Novel Applications and Technologies Widen Customer Base for Nucleic Acid Isolation
  Processes.....II-4
FDA Licenses Nucleic Acid Tests Usage for Screening Hepatitis C and HIV.....II-4
1$100
   Usage of NAT for Screening Additional Categories of HIV in Tissues and Donated Blood
  Approved by FDA.....II-5
1$100
   What is a Nucleic Acid Test?.....II-6
Polymerase Chain Reaction or PCR Tests.....II-6
Reverse Transcriptase PCR or RT-PCR Tests.....II-6
Branched DNA or Quantiplex bDNA Tests.....II-6
Applications of NAT.....II-6
NAT for Hepatitis C Virus Infection (HCV).....II-6
1$100
   Qualitative Tests.....II-7
Clinical Uses of Qualitative Nucleic Acid Test.....II-7
Quantitative Tests.....II-7
Real-Time PCR Method.....II-7
Use of NAA for Diagnosing Tuberculosis.....II-7
1$100
   Factors Hindering the Adoptability of NAA Tests for Tuberculosis.....II-8
Use of NAA for Diagnosing STI.....II-8
1$100
   Use of Nucleic Acid Sequence-Based Amplification for Diagnosing Dengue Viral
  RNA.....II-9
Segments of NAT Technology.....II-9
Amplified Probe Technology.....II-9
Signal Amplification.....II-9
Probe Amplification.....II-9
1$100
   Target Amplification.....II-10
Direct Nucleic Acid Probes.....II-10
Types of Techniques.....II-10
In-situ hybridization (ISH).....II-10
Southern Blot.....II-10
Liquid Hybridization.....II-10
Working Procedure of Nucleic Acid Tests.....II-10
Impediments for Using Technology.....II-10
Capturing Methods for Discovering Nucleic Acid Lateral Flow (NALF).....II-10
1$100
   Multiplex Nucleic Acid Testing.....II-111$100
   Regional Market Perspective.....II-12
4a. THE UNITED STATES.....II-12
A. Market Analysis.....II-12
Outlook.....II-12
A Snapshot of the US Nucleic Acid Testing Market.....II-12
Soaring Demand from Various Applications Drives the US NAPI Market.....II-12
1$100
   Use of NAT in STDs and HPV.....II-13
B. Market Analytics.....II-13
Table 1: US Recent Past, Current & Future Analysis for Nucleic Acid Testing Markets with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-13
1$350
   4b. REST OF WORLD.....II-14
A. Market Analysis.....II-14
Outlook.....II-14
Overview of Select Regional Markets.....II-14
Europe.....II-14
A Glance at the Europe’s Nucleic Acid Testing and Blood Safety Market.....II-14
1$100
   Table 2: European Recent Past, Current & Future Analysis for Nucleic Acid-based Amplification Reagents by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-151$350
   Table 3: European 10-Year Perspective for Nucleic Acid-based Amplification Reagents by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-161$350
   Table 4: European Recent Past, Current & Future Analysis for Nucleic Acid-based Amplification Reagents by Segment - Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-171$350
   Table 5: European 10-Year Perspective for Nucleic Acid-based Amplification Reagents by Segment - Percentage Breakdown of Revenues for Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-18
China.....II-18
Chinese Nucleic Acid Testing Market: An Overview.....II-18
1$350
   B. Market Analytics.....II-19
Table 6: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Testing Market with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-19
1$350
   DaAn Gene Unveils Nucleic Acid Testing Kit for Influenza A H1N1 Virus.....II-20
Sequenom Launches SensiGene Cystic Fibrosis Carrier Screening Test.....II-20
Jeevan Introduces Nucleic Acid Testing.....II-20
1$100
   Gen-Probe Acquires Prodesse.....II-21
STRATEC Takes Over Invitek.....II-21
Becton, Dickinson and Company Takes Over Handy Lab.....II-21
Gen-Probe Acquires Tepnel Life Sciences.....II-21
Micronics and Biosearch Technologies Ink Licensing Agreement.....II-21
1$100
   Quidel and BioHelix Sign Agreement.....II-22
BlueGnome Signs Agreement with Rubicon Genomics.....II-22
DaAn Gene to Setup Four Joint Ventures.....II-22
1$100
   Gen-Probe and Chiron to Extend Partnership.....II-23
EnviroLogix Inks Licensing Agreement with Ionian Technologies.....II-23
HandyLab Extends Partnership with Epoch Biosciences.....II-23
1$100
   QIAGEN to Provide Molecular Testing Solutions to Bio-Manguinhos.....II-24
Nanogen Signs Licensing and Supply Agreement with HandyLab.....II-24
Blood System Laboratories and Florida Blood Services Establish a Joint Venture.....II-24
1$100
   Teva Collaborates with Compugen.....II-25
QIAGEN Takes-Over Biotage’s Biosystems Unit.....II-25
QIAGEN Snaps Up Corbett Life Science.....II-25
Agilent Technologies to Expand API Manufacturing Plant.....II-25
1$100
   Polyclone Bioservices to Establish Nucleic Acid Testing Units in India.....II-26
Pacgen Biopharmaceuticals Signs LoI with Medigen Biotechnology.....II-26
easyDNA Establishes New DNA Testing Center in India.....II-26
Apollo Chennai Establishes Nucleic Acid Testing Unit.....II-26
1$100
   Nanosphere Receives FDA Approval for Respiratory Virus Assay.....II-27
Roche Diagnostics Obtains FDA Approval for Broader Usage of Nucleic Acid Test.....II-27
US and European Patent Authorities Award Patents to Gen-Probe for NAT.....II-27
The National Institute of Allergy and Infectious Diseases Awards $770,000 to
  Micronics.....II-27
1$100
   DaAn Gene Obtains SFDA Approval for Marketing Nucleic Acid Test Kits.....II-28
Luminex Molecular Diagnostics xTAG Respiratory Viral Panel Approved by FDA.....II-28
Siemens Healthcare’s Apple iMac OSX Operating System Approved by FDA.....II-28
Micronics Receives NIH Grant for Developing HIV POC Test.....II-28
1$100
   Abbott Laboratories, Inc. (US).....II-29
Agilent Life Sciences and Chemical Analysis (US).....II-29
Applied Biosystems Group (US).....II-29
1$100
   Becton, Dickinson and Company (US).....II-30
Bio-Rad Laboratories, Inc. (US).....II-30
1$100
   Cepheid, Inc. (US).....II-31
Genomic Health, Inc. (US).....II-31
Gen-Probe Inc. (US).....II-31
1$100
   Genzyme Corp. (US).....II-32
Genzyme Genetics (US).....II-32
Myriad Genetics, Inc. (US).....II-32
1$100
   Novartis AG (Switzerland).....II-33
QIAGEN NV (Netherlands).....II-33
Roche Diagnostics (US).....II-33
1$100
   Siemens Healthcare Diagnostics, Inc. (US).....II-34
Third Wave Technologies, Inc. (US).....II-34
1$100
   Table 7: World Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-351$350
   Table 8: World 10-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Revenues for US and Rest of World Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-361$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com